Sean Brynjelsen E.'s most recent trade in Eton Pharmaceuticals Inc was a trade of 70,000 Common Stock done at an average price of $16.8 . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eton Pharmaceuticals Inc | Sean E. Brynjelsen | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.81 per share. | 03 Jun 2025 | 70,000 | 2,873,513 (16%) | 0% | 16.8 | 1,176,700 | Common Stock |
| Eton Pharmaceuticals Inc | Sean E. Brynjelsen | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 03 Jun 2025 | 70,000 | 2,943,513 (16%) | 0% | 17 | 1,190,000 | Common Stock |
| Eton Pharmaceuticals Inc | Sean E. Brynjelsen | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 17.38 per share. | 03 Jun 2025 | 60,945 | 3,022,568 (16%) | 0% | 17.4 | 1,059,224 | Common Stock |
| Eton Pharmaceuticals Inc | Sean E. Brynjelsen | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 18.38 per share. | 03 Jun 2025 | 8,655 | 3,013,913 (16%) | 0% | 18.4 | 159,079 | Common Stock |
| Eton Pharmaceuticals Inc | Sean E. Brynjelsen | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 19.02 per share. | 03 Jun 2025 | 400 | 3,013,513 (16%) | 0% | 19.0 | 7,608 | Common Stock |
| Eton Pharmaceuticals Inc | Sean E. Brynjelsen | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 107,469 | 107,469 | - | - | Employee Stock Option (Right to Buy) | |
| Eton Pharmaceuticals Inc | Sean E. Brynjelsen | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 72,004 | 72,004 | - | - | Restricted Stock Units | |
| Eton Pharmaceuticals Inc | Sean Brynjelsen E. | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 438,633 | 2,473,014 | - | - | Stock Option (Right to buy) | |
| Eton Pharmaceuticals Inc | Sean E. Brynjelsen | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 350,381 | 1,951,881 | - | - | Stock Option (Right to buy) | |
| Eton Pharmaceuticals Inc | Sean E. Brynjelsen | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.10 per share. | 22 Sep 2022 | 10,000 | 1,040,000 (5%) | 0% | 2.1 | 21,042 | Common Stock |
| Eton Pharmaceuticals Inc | Sean E. Brynjelsen | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2022 | 110,000 | 110,000 | - | - | Restricted Stock Units | |
| Eton Pharmaceuticals Inc | Sean E. Brynjelsen | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 416,500 | 1,601,500 | - | - | Stock Option(Right to buy) | |
| Eton Pharmaceuticals Inc | Sean E. Brynjelsen | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 4.32 per share. | 20 Aug 2021 | 10,000 | 1,030,000 (5%) | 0% | 4.3 | 43,200 | Common Stock |
| Eton Pharmaceuticals Inc | Sean E. Brynjelsen | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 5.96 per share. | 03 Jun 2021 | 5,000 | 1,030,000 (5%) | 0% | 6.0 | 29,800 | Common Stock |
| Eton Pharmaceuticals Inc | Sean E. Brynjelsen | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 245,000 | 1,185,000 | - | - | Stock Option(Right to buy) |